AviadoBio
aviadobio.comLocations
England, UK · United Kingdom · London, UK · Mile End, London, UK
industry
Biotechnology · DeepTech · Health
Size
51-200 employees
Stage
Series A
founded in
2019
AviadoBio mission is to transform the lives of people living with neurodegenerative disorders by developing and delivering transformative gene therapies for diseases including frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS). The Company’s technology is based on pioneering research from King’s College London and the UK Dementia Research Institute.
Something looks off?Open jobs at AviadoBio
This company does not have jobs relevant to this job board at this time.
To view all their jobs, visit their website.